Global Gene Synthesis Market Size, Share & Industry Trends Analysis Report By Method, By Service Type, By Application, By End User, By Regional Outlook, Strategy, Challenges and Forecast, 2021 - 2027

The Global Gene Synthesis Market size is expected to reach $5.2 billion by 2027, rising at a market growth of 17.9% CAGR during the forecast period.

Gene synthesis is the process of developing or generating artificial genes through scientific processes. In addition, Gene synthesis refers to the process in which genes are developed through various methods intending to assemble and construct genes from the nucleotide. A nucleotide is a basic and fundamental block in the process of building nucleic acid.

In fact, RNA and DNA are formed by long chains of nucleotides. These substances consist of sugar molecules attached to a group of phosphate and a base that contains nitrogen. The Gene synthesis process allows the scientist and researchers to specify and personalize the desired sequence directly.

The number of research and development in genomics and advanced sequencing is rapidly rising and carries the potentials to enhance the future of the gene synthesis market. Also, the rising scale of investments and funding by the government would also develop the field of gene synthesis.

Artificial gene synthesis, which is also called DNA synthesis, is a different form of Gene synthesis. The DNA synthesis in living cells occurs when gene molecules get synthesized by all living cells through a process of DNA replication.

DNA replication is a process in which a double-stranded gene molecule is copied with the purpose to make two similar DNA molecules. Unlike the natural gene synthesis procedure, artificial gene synthesis does not need any template to copy DNA molecules. Instead, it allows any virtually developed DNA sequence to be synthesized.

COVID-19 Impact Analysis

Due to the COVID-19 outbreak, economies across the world were greatly slammed. Various industries were shut due to the government protocols that were applied to restrict the spread of the coronavirus. During the lockdown enforced by the government, numerous markets faced a great downfall while certain industries observed a booming growth during the period.

The Healthcare sector of all the regions and countries were overwhelmed and simultaneously witnessed a massive demand for different healthcare services. A number of recognized biopharmaceutical and pharmaceutical organizations as well as various synthetic biology centric companies contributed to researches across the world by offering synthetic biology expertise for building vaccines, test kits, and treatments to tackle the COVID-19 spread.

Market Growth Factors:

Rising efforts toward clinical researches to study biological systems

There is an increase in the efforts to conduct clinical researches with the aim to study the generated insights of the biological systems at the base of the molecular level. A biological system is a conceptual framework that is utilized by numerous researchers to further study the complicated biological processes. More researches in this field instigate an increase in the number of gene synthesis procedures. Researches associated with the biological system require a variety of studies respective to various aspects of DNA and gene synthesis.

Booming demand for personalized medicines

In the present scenario, a lot of people are undergoing distinct medication programs due to a variety of diseases. The medicines are produced with the purpose of generalized usage comprising various salts and other components. Regular medicines are distributed among people on the basis of the requirement of their treatment. The acids and salts along with other elements which are comprised in the generalized medicines do not suit everyone.

Marketing Restraining Factor:

Concerns regarding biosecurity, biosafety, and ethics

The number of researches in the field of gene synthesis is continuously increasing. The practices being performed during these researches involve different types of synthetic organisms. In addition, increasing researches and developments generate the risk of the outbreak of these synthetic organisms in the environment which could be a major challenge to biosafety concerns.

Method Outlook

Based on method, the gene synthesis market is classified into Chip-based, solid phase, and PCR-based Enzyme Synthesis. In 2020, the solid-phase gene synthesis segment held the biggest revenue share of the gene synthesis market. The solid phase refers to a traditional artificial gene production technique that displays a higher accuracy rate. In the solid-phase gene synthesis method, the molecules are engaged in an ionic bond on a solid surface named controlled porosity glass beads which are equipped with synthesis columns and individually synthesized.

Service Type Outlook

Based on service, the gene synthesis market is divided into Antibody DNA, Viral DNA, and Others. In 2020, the antibody DNA segment attained the highest revenue share of the gene synthesis market and would continue to lead the market during the forecasting period. The growth of the segment is attributed to the rising number of companies destined to fulfill the significant demand for this antibody DNA service. The antibody DNA synthesis is conducted with restriction enzyme digestion which is followed by ligation and transformation or transfection.

Application Outlook

Based on application, the gene synthesis market is segmented into Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis, and Others. In 2020, the gene and cell therapy segment held the biggest revenue share of the gene synthesis market. In addition, the growth of this segment is a result of the increasing number of initiatives being taken for the development of gene and cell therapy. Gene therapy is the procedure of transmission of the genetic materials through a vector or a carrier and the delivery of the DNA to the appropriate cell.

End User Outlook

Based on End-user, the gene synthesis market is segregated into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations (CROs). In 2020, the academics and government research institutes segment procured the maximum revenue share of the market. This is credited to the rising preference of people for research settings for investigation and clinical research programs to conduct DNA synthesis practices. Also, the rising number of developments and discoveries in the biotechnology and pharmaceuticals is a factor that is responsible for increasing the number of new players in the market.

Gene Synthesis Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 1.6 Billion
Market size forecast in 2027	USD 5.2 Billion
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 17.9% from 2021 to 2027
Number of Pages	275
Number of Tables	454
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Method, Service Type, Application, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising efforts toward clinical researches to study biological systems Booming demand for personalized medicines
Restraints	Concerns regarding biosecurity, biosafety, and ethics

Regional Outlook

Based on region, the gene synthesis market is analyzed across North America, Europe, APAC, and LAMEA. In 2020, North America dominated the gene synthesis market by acquiring the highest revenue share of the market. North America is observing a constantly rising demand for development in gene synthesis applications for biopharmaceutical companies and academic institutes. Moreover, the increasing number of developments in medication based on gene synthesis therapy is also considered to accelerate the development of the market.

Free Valuable Insights: Global Gene Synthesis Market size to reach USD 5.2 Billion by 2027

KBV Cardinal Matrix - Gene Synthesis Market Competition Analysis

The major strategies followed by the market participants are Acquisitions and Partnerships. Based on the Analysis presented in the Thermo Fisher Scientific, Inc. is the major forerunner in the Gene Synthesis Market. Companies such as Danaher Corporation, Brooks Automation, Inc., Genscript Biotech Corporation are some of the key innovators in the Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Genscript Biotech Corporation, Thermo Fisher Scientific, Inc., Brooks Automation, Inc., Boster Biological Technology, Twist Bioscience Corporation, Danaher Corporation, Biomatik Corporation, ProteoGenix, ProMab Biotechnologies, Inc., and OriGene Technologies, Inc.

Recent Strategies Deployed in Gene Synthesis Market

» Partnerships, Collaborations and Agreements:

• Aug-2021: GenScript teamed up with Allozymes, a synthetic biology firm. Following this collaboration, GenScript would integrate its robust excellence in de novo gene synthesis capabilities along with its highly advanced semiconductor-based oligo synthesis technology into a patented screening platform of Allozymes intending to provide pinpoint control of every synthesized variant in order to attain an assorted and fully covered mutant range with the impartial distribution. Moreover, the companies would focus on obtaining substantial breakthroughs in protein engineering research.
• Aug-2021: Twist Bioscience joined hands with SomaLogic, a US-based protein biomarker discovery and clinical diagnostics company. Through this collaboration, the company aimed to innovate novel antibodies key disease biomarkers-based drug discovery. In addition, this collaboration would allow Twist Biosciences to leverage the SomaScan platform of SomaLogic with the purpose of rapidly identifying antibodies against targets with the help of SomaLogic’s best-in-class 7,000-plex assay which is one of the broadest views of the proteome available.
• Jun-2021: Twist Bioscience collaborated with Regeneron Genetics Center, a subsidiary of Regeneron. Through this collaboration, Twist Biosciences aimed to optimize the assay with content gathered from various cultures that enables increased characterization of various populations intending to enhance understanding across disease along with possible therapeutic development.
• Jun-2021: Thermo Fisher Scientific collaborated with the University of Sheffield, a leading institution with a global reputation for research excellence. Through this collaboration, the companies aimed to develop cutting-edge end-to-end workflows for monitoring and characterizing complicated oligonucleotide and mRNA products. In addition, the collaboration would integrate extensive research excellence of the University of Sheffield into advanced sample preparation, high-resolution accurate mass, liquid chromatography data interpretation software technologies, and mass spectrometry to allow the development of streamlined analytical workflows and robust fit-for-purpose processes.
• Mar-2021: Twist Bioscience entered into a partnership with Watchmaker Genomics, a biotechnology company based in the US. Through this partnership, the companies aimed to provide distinct products that facilitate and streamline workflows before putting samples on the sequencer. Moreover, this partnership would enable innovative research across a broad line of high throughput sequencing applications including inherited disease detection, minimal residual disease monitoring, liquid biopsy assays, and oncology and tumor profiling.
• Oct-2020: Twist Bioscience partnered with Neogene Therapeutics, a biotechnology company. This partnership would allow the company to accelerate genetic engineering and identification of TCR genes by integrating platforms of both companies with the purpose to innovate customized T cell therapies for cancer. Moreover, the companies aimed to break the barriers of limitations of currently available treatments
• Jan-2020: GenScript entered into a partnership with Genopis, an expert in plasmid DNA-based technology and provider of contract development and manufacturing organization services. Under this partnership, GenScript would leverage Genopis's manufacturing service of GMP Plasmids with the purpose to allow customers to reduce the cost and time of R&D. In addition, this partnership would facilitate customers to efficiently diversify risks while leveraging resources in the early R&D phase.

» Acquisitions and Mergers:

• Nov-2021: Twist Bioscience completed its acquisition of Abveris, a private in vivo antibody discovery services company. With this acquisition, the company aimed to enable its ability to pair natural, in vivo antibody development with its best-in-class humanization and engineering potentials intending to enrich antibody discovery with a new gold standard.
• Jun-2021: Danaher acquired Aldevron, a US-based biotech company. Through this acquisition, the company aimed to strengthen its capabilities in genomic medicines and offer support to its vision of discovering more life-saving therapies and vaccines to market rapidly.
• Mar-2021: Integrated DNA Technologies, a subsidiary of Danaher Corporation took over Swift Biosciences, a pioneer in the development of Next-Generation Sequencing (NGS) library preparation genomics kits. Under this acquisition, the company aimed to integrate Swift Biosciences' wide range of library preparation and enrichment products into its portfolio of high-quality NGS products intending to allow scientists to conduct more efficient research.
• Jan-2021: Thermo Fisher Scientific acquired Henogen, a Belgium-based viral vector manufacturing subsidiary of Novasep. Following this acquisition, the company would leverage Novasep's capabilities to expand its portfolio of cell and gene vaccines and therapies globally. Moreover, this acquisition would allow the company to benefit its global customers seeking support and capacity in the region while bringing new medicines for patients in or outside of Europe.

» Product Launches and Product Expansions:

• Nov-2021: GenScript USA rolled out GenWand, a Double-Stranded DNA service. Through this launch, the company aimed to offer enhanced efficiency along with reduced toxicity to the manufacturers of CRISPR knock-in homology-directed repair (HDR) templates in T cell engineering while performing gene knock-in. Additionally, the new GenWand is an ideal solution for large-scale screening and scale-up in cell and gene therapy.
• Oct-2021: Twist Bioscience rolled out its Exome 2.0, featuring complete analysis of protein-coding and non-coding regions of the genome while reducing downstream costs. Through this launch, the company aimed to offer an all-inclusive range of flexible and comprehensive exome options intending to assist genomics researchers seeking to find out the origins of disease.
• Dec-2020: Twist Bioscience released Clonal-Ready Gene Fragments, the best-in-class Gene Fragments of the company. Through this launch, the company aimed to offer a complete range of genes to its customers. In addition, the new Clonal-Ready Gene Fragments can be used with or without adapters to build structures in reduced time and cost of screening for perfect clones.
• Jun-2020: Integrated DNA Technologies, a subsidiary of Danaher Corporation rolled out gBlocks, HiFi Gene Fragments. Through this launch, the company aimed to offer a high-quality product with consistent fidelity to researchers intending to facilitate the building of large gene structures and eliminate the risk of unwanted mutations in their sequences. Moreover, it would allow researchers to choose 50% fewer colonies to locate their gene or pathway of interest while reducing time and money.

» Geographical Expansions:

• Nov-2021: GenScript expanded its global footprint by opening a new gene synthesis facility in the USA. Through this geographical expansion, the company aimed to establish a robust synthesis facility with expanded capabilities of synthesizing 4000-5000 genes in a month. In addition, it would also reduce the company's concern for legal constraints on the import of genes that are synthesized outside of the domestic territory of the USA along with supply chain errors and accelerate the delivery as well.
• Dec-2020: Twist Bioscience expanded its geographical footprint by opening the Factory of the Future in Oregon, Wilsonville. This geographical expansion would allow the company to fulfill the rising demand of its customers as they measure globally and plan for competitive growth in synthetic biology and biopharma segments of the market.
• Sep-2020: Integrated DNA Technologies, a subsidiary of Danaher Corporation expanded its geographical footprint by launching IDT China. Through this expansion, the company aimed to strengthen its service for customers across the country. Moreover, this expansion would allow the company to expand its reach to new customers along with facilitating access to its line of cutting-edge products.

Scope of the Study

Market Segments Covered in the Report:

By Method

• Solid-phase Synthesis
• Chip-based Synthesis and
• PCR-based Enzyme Synthesis

By Service Type

• Antibody DNA Synthesis
• Viral DNA Synthesis and
• Others

By Application

• Gene & Cell Therapy Development
• Vaccine Development
• Disease Diagnosis and
• Others

By End User

• Academic & Government Research Institutes
• Biotechnology & Pharmaceutical Companies and
• Contract Research Organizations

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Genscript Biotech Corporation
• Thermo Fisher Scientific, Inc.
• Brooks Automation, Inc.
• Boster Biological Technology
• Twist Bioscience Corporation
• Danaher Corporation
• Biomatik Corporation
• ProteoGenix
• ProMab Biotechnologies, Inc.
• OriGene Technologies, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Gene Synthesis Market, by Method
1.4.2 Global Gene Synthesis Market, by Service Type
1.4.3 Global Gene Synthesis Market, by Application
1.4.4 Global Gene Synthesis Market, by End User
1.4.5 Global Gene Synthesis Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Acquisition and Mergers
3.2.2 Partnerships, Collaborations and Agreements
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec – 2021, Nov) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul – 2021, Aug) Leading Players

Chapter 4. Global Gene Synthesis Market by Method
4.1 Global Solid-phase Synthesis Market by Region
4.2 Global Chip-based Synthesis Market by Region
4.3 Global PCR-based Enzyme Synthesis Market by Region

Chapter 5. Global Gene Synthesis Market by Service Type
5.1 Global Antibody DNA Synthesis Market by Region
5.2 Global Viral DNA Synthesis Market by Region
5.3 Global Others Market by Region

Chapter 6. Global Gene Synthesis Market by Application
6.1 Global Gene & Cell Therapy Development Market by Region
6.2 Global Vaccine Development Market by Region
6.3 Global Disease Diagnosis Market by Region
6.4 Global Others Market by Region

Chapter 7. Global Gene Synthesis Market by End User
7.1 Global Academic & Government Research Institutes Market by Region
7.2 Global Biotechnology & Pharmaceutical Companies Market by Region
7.3 Global Contract Research Organizations Market by Region

Chapter 8. Global Gene Synthesis Market by Region
8.1 North America Gene Synthesis Market
8.1.1 North America Gene Synthesis Market by Method
8.1.1.1 North America Solid-phase Synthesis Market by Country
8.1.1.2 North America Chip-based Synthesis Market by Country
8.1.1.3 North America PCR-based Enzyme Synthesis Market by Country
8.1.2 North America Gene Synthesis Market by Service Type
8.1.2.1 North America Antibody DNA Synthesis Market by Country
8.1.2.2 North America Viral DNA Synthesis Market by Country
8.1.2.3 North America Others Market by Country
8.1.3 North America Gene Synthesis Market by Application
8.1.3.1 North America Gene & Cell Therapy Development Market by Country
8.1.3.2 North America Vaccine Development Market by Country
8.1.3.3 North America Disease Diagnosis Market by Country
8.1.3.4 North America Others Market by Country
8.1.4 North America Gene Synthesis Market by End User
8.1.4.1 North America Academic & Government Research Institutes Market by Country
8.1.4.2 North America Biotechnology & Pharmaceutical Companies Market by Country
8.1.4.3 North America Contract Research Organizations Market by Country
8.1.5 North America Gene Synthesis Market by Country
8.1.5.1 US Gene Synthesis Market
8.1.5.1.1 US Gene Synthesis Market by Method
8.1.5.1.2 US Gene Synthesis Market by Service Type
8.1.5.1.3 US Gene Synthesis Market by Application
8.1.5.1.4 US Gene Synthesis Market by End User
8.1.5.2 Canada Gene Synthesis Market
8.1.5.2.1 Canada Gene Synthesis Market by Method
8.1.5.2.2 Canada Gene Synthesis Market by Service Type
8.1.5.2.3 Canada Gene Synthesis Market by Application
8.1.5.2.4 Canada Gene Synthesis Market by End User
8.1.5.3 Mexico Gene Synthesis Market
8.1.5.3.1 Mexico Gene Synthesis Market by Method
8.1.5.3.2 Mexico Gene Synthesis Market by Service Type
8.1.5.3.3 Mexico Gene Synthesis Market by Application
8.1.5.3.4 Mexico Gene Synthesis Market by End User
8.1.5.4 Rest of North America Gene Synthesis Market
8.1.5.4.1 Rest of North America Gene Synthesis Market by Method
8.1.5.4.2 Rest of North America Gene Synthesis Market by Service Type
8.1.5.4.3 Rest of North America Gene Synthesis Market by Application
8.1.5.4.4 Rest of North America Gene Synthesis Market by End User
8.2 Europe Gene Synthesis Market
8.2.1 Europe Gene Synthesis Market by Method
8.2.1.1 Europe Solid-phase Synthesis Market by Country
8.2.1.2 Europe Chip-based Synthesis Market by Country
8.2.1.3 Europe PCR-based Enzyme Synthesis Market by Country
8.2.2 Europe Gene Synthesis Market by Service Type
8.2.2.1 Europe Antibody DNA Synthesis Market by Country
8.2.2.2 Europe Viral DNA Synthesis Market by Country
8.2.2.3 Europe Others Market by Country
8.2.3 Europe Gene Synthesis Market by Application
8.2.3.1 Europe Gene & Cell Therapy Development Market by Country
8.2.3.2 Europe Vaccine Development Market by Country
8.2.3.3 Europe Disease Diagnosis Market by Country
8.2.3.4 Europe Others Market by Country
8.2.4 Europe Gene Synthesis Market by End User
8.2.4.1 Europe Academic & Government Research Institutes Market by Country
8.2.4.2 Europe Biotechnology & Pharmaceutical Companies Market by Country
8.2.4.3 Europe Contract Research Organizations Market by Country
8.2.5 Europe Gene Synthesis Market by Country
8.2.5.1 Germany Gene Synthesis Market
8.2.5.1.1 Germany Gene Synthesis Market by Method
8.2.5.1.2 Germany Gene Synthesis Market by Service Type
8.2.5.1.3 Germany Gene Synthesis Market by Application
8.2.5.1.4 Germany Gene Synthesis Market by End User
8.2.5.2 UK Gene Synthesis Market
8.2.5.2.1 UK Gene Synthesis Market by Method
8.2.5.2.2 UK Gene Synthesis Market by Service Type
8.2.5.2.3 UK Gene Synthesis Market by Application
8.2.5.2.4 UK Gene Synthesis Market by End User
8.2.5.3 France Gene Synthesis Market
8.2.5.3.1 France Gene Synthesis Market by Method
8.2.5.3.2 France Gene Synthesis Market by Service Type
8.2.5.3.3 France Gene Synthesis Market by Application
8.2.5.3.4 France Gene Synthesis Market by End User
8.2.5.4 Russia Gene Synthesis Market
8.2.5.4.1 Russia Gene Synthesis Market by Method
8.2.5.4.2 Russia Gene Synthesis Market by Service Type
8.2.5.4.3 Russia Gene Synthesis Market by Application
8.2.5.4.4 Russia Gene Synthesis Market by End User
8.2.5.5 Spain Gene Synthesis Market
8.2.5.5.1 Spain Gene Synthesis Market by Method
8.2.5.5.2 Spain Gene Synthesis Market by Service Type
8.2.5.5.3 Spain Gene Synthesis Market by Application
8.2.5.5.4 Spain Gene Synthesis Market by End User
8.2.5.6 Italy Gene Synthesis Market
8.2.5.6.1 Italy Gene Synthesis Market by Method
8.2.5.6.2 Italy Gene Synthesis Market by Service Type
8.2.5.6.3 Italy Gene Synthesis Market by Application
8.2.5.6.4 Italy Gene Synthesis Market by End User
8.2.5.7 Rest of Europe Gene Synthesis Market
8.2.5.7.1 Rest of Europe Gene Synthesis Market by Method
8.2.5.7.2 Rest of Europe Gene Synthesis Market by Service Type
8.2.5.7.3 Rest of Europe Gene Synthesis Market by Application
8.2.5.7.4 Rest of Europe Gene Synthesis Market by End User
8.3 Asia Pacific Gene Synthesis Market
8.3.1 Asia Pacific Gene Synthesis Market by Method
8.3.1.1 Asia Pacific Solid-phase Synthesis Market by Country
8.3.1.2 Asia Pacific Chip-based Synthesis Market by Country
8.3.1.3 Asia Pacific PCR-based Enzyme Synthesis Market by Country
8.3.2 Asia Pacific Gene Synthesis Market by Service Type
8.3.2.1 Asia Pacific Antibody DNA Synthesis Market by Country
8.3.2.2 Asia Pacific Viral DNA Synthesis Market by Country
8.3.2.3 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Gene Synthesis Market by Application
8.3.3.1 Asia Pacific Gene & Cell Therapy Development Market by Country
8.3.3.2 Asia Pacific Vaccine Development Market by Country
8.3.3.3 Asia Pacific Disease Diagnosis Market by Country
8.3.3.4 Asia Pacific Others Market by Country
8.3.4 Asia Pacific Gene Synthesis Market by End User
8.3.4.1 Asia Pacific Academic & Government Research Institutes Market by Country
8.3.4.2 Asia Pacific Biotechnology & Pharmaceutical Companies Market by Country
8.3.4.3 Asia Pacific Contract Research Organizations Market by Country
8.3.5 Asia Pacific Gene Synthesis Market by Country
8.3.5.1 China Gene Synthesis Market
8.3.5.1.1 China Gene Synthesis Market by Method
8.3.5.1.2 China Gene Synthesis Market by Service Type
8.3.5.1.3 China Gene Synthesis Market by Application
8.3.5.1.4 China Gene Synthesis Market by End User
8.3.5.2 Japan Gene Synthesis Market
8.3.5.2.1 Japan Gene Synthesis Market by Method
8.3.5.2.2 Japan Gene Synthesis Market by Service Type
8.3.5.2.3 Japan Gene Synthesis Market by Application
8.3.5.2.4 Japan Gene Synthesis Market by End User
8.3.5.3 India Gene Synthesis Market
8.3.5.3.1 India Gene Synthesis Market by Method
8.3.5.3.2 India Gene Synthesis Market by Service Type
8.3.5.3.3 India Gene Synthesis Market by Application
8.3.5.3.4 India Gene Synthesis Market by End User
8.3.5.4 South Korea Gene Synthesis Market
8.3.5.4.1 South Korea Gene Synthesis Market by Method
8.3.5.4.2 South Korea Gene Synthesis Market by Service Type
8.3.5.4.3 South Korea Gene Synthesis Market by Application
8.3.5.4.4 South Korea Gene Synthesis Market by End User
8.3.5.5 Singapore Gene Synthesis Market
8.3.5.5.1 Singapore Gene Synthesis Market by Method
8.3.5.5.2 Singapore Gene Synthesis Market by Service Type
8.3.5.5.3 Singapore Gene Synthesis Market by Application
8.3.5.5.4 Singapore Gene Synthesis Market by End User
8.3.5.6 Malaysia Gene Synthesis Market
8.3.5.6.1 Malaysia Gene Synthesis Market by Method
8.3.5.6.2 Malaysia Gene Synthesis Market by Service Type
8.3.5.6.3 Malaysia Gene Synthesis Market by Application
8.3.5.6.4 Malaysia Gene Synthesis Market by End User
8.3.5.7 Rest of Asia Pacific Gene Synthesis Market
8.3.5.7.1 Rest of Asia Pacific Gene Synthesis Market by Method
8.3.5.7.2 Rest of Asia Pacific Gene Synthesis Market by Service Type
8.3.5.7.3 Rest of Asia Pacific Gene Synthesis Market by Application
8.3.5.7.4 Rest of Asia Pacific Gene Synthesis Market by End User
8.4 LAMEA Gene Synthesis Market
8.4.1 LAMEA Gene Synthesis Market by Method
8.4.1.1 LAMEA Solid-phase Synthesis Market by Country
8.4.1.1.1 LAMEA Chip-based Synthesis Market by Country
8.4.1.1.2 LAMEA PCR-based Enzyme Synthesis Market by Country
8.4.1.2 LAMEA Gene Synthesis Market by Service Type
8.4.1.2.1 LAMEA Antibody DNA Synthesis Market by Country
8.4.1.2.2 LAMEA Viral DNA Synthesis Market by Country
8.4.1.2.3 LAMEA Others Market by Country
8.4.2 LAMEA Gene Synthesis Market by Application
8.4.2.1 LAMEA Gene & Cell Therapy Development Market by Country
8.4.2.2 LAMEA Vaccine Development Market by Country
8.4.2.3 LAMEA Disease Diagnosis Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA Gene Synthesis Market by End User
8.4.3.1 LAMEA Academic & Government Research Institutes Market by Country
8.4.3.2 LAMEA Biotechnology & Pharmaceutical Companies Market by Country
8.4.3.3 LAMEA Contract Research Organizations Market by Country
8.4.4 LAMEA Gene Synthesis Market by Country
8.4.4.1 Brazil Gene Synthesis Market
8.4.4.1.1 Brazil Gene Synthesis Market by Method
8.4.4.1.2 Brazil Gene Synthesis Market by Service Type
8.4.4.1.3 Brazil Gene Synthesis Market by Application
8.4.4.1.4 Brazil Gene Synthesis Market by End User
8.4.4.2 Argentina Gene Synthesis Market
8.4.4.2.1 Argentina Gene Synthesis Market by Method
8.4.4.2.2 Argentina Gene Synthesis Market by Service Type
8.4.4.2.3 Argentina Gene Synthesis Market by Application
8.4.4.2.4 Argentina Gene Synthesis Market by End User
8.4.4.3 UAE Gene Synthesis Market
8.4.4.3.1 UAE Gene Synthesis Market by Method
8.4.4.3.2 UAE Gene Synthesis Market by Service Type
8.4.4.3.3 UAE Gene Synthesis Market by Application
8.4.4.3.4 UAE Gene Synthesis Market by End User
8.4.4.4 Saudi Arabia Gene Synthesis Market
8.4.4.4.1 Saudi Arabia Gene Synthesis Market by Method
8.4.4.4.2 Saudi Arabia Gene Synthesis Market by Service Type
8.4.4.4.3 Saudi Arabia Gene Synthesis Market by Application
8.4.4.4.4 Saudi Arabia Gene Synthesis Market by End User
8.4.4.5 South Africa Gene Synthesis Market
8.4.4.5.1 South Africa Gene Synthesis Market by Method
8.4.4.5.2 South Africa Gene Synthesis Market by Service Type
8.4.4.5.3 South Africa Gene Synthesis Market by Application
8.4.4.5.4 South Africa Gene Synthesis Market by End User
8.4.4.6 Nigeria Gene Synthesis Market
8.4.4.6.1 Nigeria Gene Synthesis Market by Method
8.4.4.6.2 Nigeria Gene Synthesis Market by Service Type
8.4.4.6.3 Nigeria Gene Synthesis Market by Application
8.4.4.6.4 Nigeria Gene Synthesis Market by End User
8.4.4.7 Rest of LAMEA Gene Synthesis Market
8.4.4.7.1 Rest of LAMEA Gene Synthesis Market by Method
8.4.4.7.2 Rest of LAMEA Gene Synthesis Market by Service Type
8.4.4.7.3 Rest of LAMEA Gene Synthesis Market by Application
8.4.4.7.4 Rest of LAMEA Gene Synthesis Market by End User

Chapter 9. Company Profiles
9.1 Genscript Biotech Corporation
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional & Segmental Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.5.4 Geographical Expansions:
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Acquisition and Mergers:
9.2.5.3 Geographical Expansions:
9.2.6 SWOT Analysis
9.3 Brooks Automation, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional & Segmental Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Boster Biological Technology
9.4.1 Company Overview
9.5 Twist Bioscience Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional & Segmental Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.5.5.3 Product Launches and Product Expansions:
9.5.5.4 Geographical Expansions:
9.6 Danaher Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.6.5.2 Acquisition and Mergers:
9.6.5.3 Geographical Expansions:
9.7 Biomatik Corporation
9.7.1 Company Overview
9.8 ProteoGenix
9.8.1 Company Overview
9.9 ProMab Biotechnologies, Inc.
9.9.1 Company Overview
9.10. OriGene Technologies, Inc.
9.10.1 Company Overview

TABLE 1 Global Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 2 Global Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 3 Acquisition and Mergers– Gene Synthesis Market
TABLE 4 Partnerships, Collaborations and Agreements– Gene Synthesis Market
TABLE 5 Product Launches And Product Expansions– Gene Synthesis Market
TABLE 6 Geographical Expansions– Gene Synthesis Market
TABLE 7 Global Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 8 Global Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 9 Global Solid-phase Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Solid-phase Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Chip-based Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Chip-based Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 13 Global PCR-based Enzyme Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 14 Global PCR-based Enzyme Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 15 Global Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 16 Global Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 17 Global Antibody DNA Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Antibody DNA Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Viral DNA Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Viral DNA Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 21 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 22 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 23 Global Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 24 Global Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 25 Global Gene & Cell Therapy Development Market by Region, 2017 - 2020, USD Million
TABLE 26 Global Gene & Cell Therapy Development Market by Region, 2021 - 2027, USD Million
TABLE 27 Global Vaccine Development Market by Region, 2017 - 2020, USD Million
TABLE 28 Global Vaccine Development Market by Region, 2021 - 2027, USD Million
TABLE 29 Global Disease Diagnosis Market by Region, 2017 - 2020, USD Million
TABLE 30 Global Disease Diagnosis Market by Region, 2021 - 2027, USD Million
TABLE 31 Global Others Market by Region, 2017 - 2020, USD Million
TABLE 32 Global Others Market by Region, 2021 - 2027, USD Million
TABLE 33 Global Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 34 Global Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 35 Global Academic & Government Research Institutes Market by Region, 2017 - 2020, USD Million
TABLE 36 Global Academic & Government Research Institutes Market by Region, 2021 - 2027, USD Million
TABLE 37 Global Biotechnology & Pharmaceutical Companies Market by Region, 2017 - 2020, USD Million
TABLE 38 Global Biotechnology & Pharmaceutical Companies Market by Region, 2021 - 2027, USD Million
TABLE 39 Global Contract Research Organizations Market by Region, 2017 - 2020, USD Million
TABLE 40 Global Contract Research Organizations Market by Region, 2021 - 2027, USD Million
TABLE 41 Global Gene Synthesis Market by Region, 2017 - 2020, USD Million
TABLE 42 Global Gene Synthesis Market by Region, 2021 - 2027, USD Million
TABLE 43 North America Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 44 North America Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 45 North America Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 46 North America Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 47 North America Solid-phase Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 48 North America Solid-phase Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 49 North America Chip-based Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 50 North America Chip-based Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 51 North America PCR-based Enzyme Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 52 North America PCR-based Enzyme Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 53 North America Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 54 North America Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 55 North America Antibody DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 56 North America Antibody DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 57 North America Viral DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 58 North America Viral DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 59 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 60 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 61 North America Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 62 North America Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 63 North America Gene & Cell Therapy Development Market by Country, 2017 - 2020, USD Million
TABLE 64 North America Gene & Cell Therapy Development Market by Country, 2021 - 2027, USD Million
TABLE 65 North America Vaccine Development Market by Country, 2017 - 2020, USD Million
TABLE 66 North America Vaccine Development Market by Country, 2021 - 2027, USD Million
TABLE 67 North America Disease Diagnosis Market by Country, 2017 - 2020, USD Million
TABLE 68 North America Disease Diagnosis Market by Country, 2021 - 2027, USD Million
TABLE 69 North America Others Market by Country, 2017 - 2020, USD Million
TABLE 70 North America Others Market by Country, 2021 - 2027, USD Million
TABLE 71 North America Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 72 North America Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 73 North America Academic & Government Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 74 North America Academic & Government Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 75 North America Biotechnology & Pharmaceutical Companies Market by Country, 2017 - 2020, USD Million
TABLE 76 North America Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2027, USD Million
TABLE 77 North America Contract Research Organizations Market by Country, 2017 - 2020, USD Million
TABLE 78 North America Contract Research Organizations Market by Country, 2021 - 2027, USD Million
TABLE 79 North America Gene Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 80 North America Gene Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 81 US Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 82 US Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 83 US Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 84 US Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 85 US Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 86 US Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 87 US Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 88 US Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 89 US Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 90 US Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 91 Canada Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 92 Canada Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 93 Canada Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 94 Canada Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 95 Canada Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 96 Canada Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 97 Canada Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 98 Canada Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 99 Canada Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 100 Canada Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 101 Mexico Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 102 Mexico Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 103 Mexico Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 104 Mexico Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 105 Mexico Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 106 Mexico Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 107 Mexico Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 108 Mexico Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 109 Mexico Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 110 Mexico Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 111 Rest of North America Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 112 Rest of North America Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 113 Rest of North America Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 114 Rest of North America Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 115 Rest of North America Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 116 Rest of North America Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 117 Rest of North America Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 118 Rest of North America Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 119 Rest of North America Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 120 Rest of North America Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 121 Europe Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 122 Europe Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 123 Europe Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 124 Europe Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 125 Europe Solid-phase Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 126 Europe Solid-phase Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 127 Europe Chip-based Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 128 Europe Chip-based Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 129 Europe PCR-based Enzyme Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 130 Europe PCR-based Enzyme Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 131 Europe Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 132 Europe Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 133 Europe Antibody DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 134 Europe Antibody DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 135 Europe Viral DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 136 Europe Viral DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 137 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 138 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 139 Europe Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 140 Europe Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 141 Europe Gene & Cell Therapy Development Market by Country, 2017 - 2020, USD Million
TABLE 142 Europe Gene & Cell Therapy Development Market by Country, 2021 - 2027, USD Million
TABLE 143 Europe Vaccine Development Market by Country, 2017 - 2020, USD Million
TABLE 144 Europe Vaccine Development Market by Country, 2021 - 2027, USD Million
TABLE 145 Europe Disease Diagnosis Market by Country, 2017 - 2020, USD Million
TABLE 146 Europe Disease Diagnosis Market by Country, 2021 - 2027, USD Million
TABLE 147 Europe Others Market by Country, 2017 - 2020, USD Million
TABLE 148 Europe Others Market by Country, 2021 - 2027, USD Million
TABLE 149 Europe Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 150 Europe Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 151 Europe Academic & Government Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 152 Europe Academic & Government Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 153 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2017 - 2020, USD Million
TABLE 154 Europe Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2027, USD Million
TABLE 155 Europe Contract Research Organizations Market by Country, 2017 - 2020, USD Million
TABLE 156 Europe Contract Research Organizations Market by Country, 2021 - 2027, USD Million
TABLE 157 Europe Gene Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 158 Europe Gene Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 159 Germany Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 160 Germany Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 161 Germany Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 162 Germany Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 163 Germany Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 164 Germany Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 165 Germany Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 166 Germany Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 167 Germany Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 168 Germany Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 169 UK Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 170 UK Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 171 UK Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 172 UK Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 173 UK Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 174 UK Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 175 UK Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 176 UK Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 177 UK Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 178 UK Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 179 France Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 180 France Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 181 France Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 182 France Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 183 France Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 184 France Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 185 France Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 186 France Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 187 France Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 188 France Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 189 Russia Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 190 Russia Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 191 Russia Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 192 Russia Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 193 Russia Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 194 Russia Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 195 Russia Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 196 Russia Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 197 Russia Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 198 Russia Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 199 Spain Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 200 Spain Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 201 Spain Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 202 Spain Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 203 Spain Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 204 Spain Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 205 Spain Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 206 Spain Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 207 Spain Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 208 Spain Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 209 Italy Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 210 Italy Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 211 Italy Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 212 Italy Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 213 Italy Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 214 Italy Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 215 Italy Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 216 Italy Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 217 Italy Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 218 Italy Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 219 Rest of Europe Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 220 Rest of Europe Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 221 Rest of Europe Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 222 Rest of Europe Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 223 Rest of Europe Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 224 Rest of Europe Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 225 Rest of Europe Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 226 Rest of Europe Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 227 Rest of Europe Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 228 Rest of Europe Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 229 Asia Pacific Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 230 Asia Pacific Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 231 Asia Pacific Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 232 Asia Pacific Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 233 Asia Pacific Solid-phase Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 234 Asia Pacific Solid-phase Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 235 Asia Pacific Chip-based Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 236 Asia Pacific Chip-based Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 237 Asia Pacific PCR-based Enzyme Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 238 Asia Pacific PCR-based Enzyme Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 239 Asia Pacific Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 240 Asia Pacific Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 241 Asia Pacific Antibody DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 242 Asia Pacific Antibody DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 243 Asia Pacific Viral DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 244 Asia Pacific Viral DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 245 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 246 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 247 Asia Pacific Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 248 Asia Pacific Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 249 Asia Pacific Gene & Cell Therapy Development Market by Country, 2017 - 2020, USD Million
TABLE 250 Asia Pacific Gene & Cell Therapy Development Market by Country, 2021 - 2027, USD Million
TABLE 251 Asia Pacific Vaccine Development Market by Country, 2017 - 2020, USD Million
TABLE 252 Asia Pacific Vaccine Development Market by Country, 2021 - 2027, USD Million
TABLE 253 Asia Pacific Disease Diagnosis Market by Country, 2017 - 2020, USD Million
TABLE 254 Asia Pacific Disease Diagnosis Market by Country, 2021 - 2027, USD Million
TABLE 255 Asia Pacific Others Market by Country, 2017 - 2020, USD Million
TABLE 256 Asia Pacific Others Market by Country, 2021 - 2027, USD Million
TABLE 257 Asia Pacific Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 258 Asia Pacific Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 259 Asia Pacific Academic & Government Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 260 Asia Pacific Academic & Government Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 261 Asia Pacific Biotechnology & Pharmaceutical Companies Market by Country, 2017 - 2020, USD Million
TABLE 262 Asia Pacific Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2027, USD Million
TABLE 263 Asia Pacific Contract Research Organizations Market by Country, 2017 - 2020, USD Million
TABLE 264 Asia Pacific Contract Research Organizations Market by Country, 2021 - 2027, USD Million
TABLE 265 Asia Pacific Gene Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 266 Asia Pacific Gene Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 267 China Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 268 China Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 269 China Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 270 China Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 271 China Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 272 China Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 273 China Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 274 China Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 275 China Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 276 China Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 277 Japan Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 278 Japan Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 279 Japan Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 280 Japan Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 281 Japan Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 282 Japan Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 283 Japan Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 284 Japan Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 285 Japan Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 286 Japan Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 287 India Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 288 India Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 289 India Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 290 India Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 291 India Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 292 India Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 293 India Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 294 India Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 295 India Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 296 India Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 297 South Korea Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 298 South Korea Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 299 South Korea Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 300 South Korea Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 301 South Korea Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 302 South Korea Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 303 South Korea Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 304 South Korea Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 305 South Korea Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 306 South Korea Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 307 Singapore Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 308 Singapore Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 309 Singapore Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 310 Singapore Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 311 Singapore Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 312 Singapore Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 313 Singapore Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 314 Singapore Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 315 Singapore Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 316 Singapore Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 317 Malaysia Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 318 Malaysia Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 319 Malaysia Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 320 Malaysia Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 321 Malaysia Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 322 Malaysia Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 323 Malaysia Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 324 Malaysia Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 325 Malaysia Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 326 Malaysia Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 327 Rest of Asia Pacific Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 328 Rest of Asia Pacific Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 329 Rest of Asia Pacific Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 330 Rest of Asia Pacific Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 331 Rest of Asia Pacific Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 332 Rest of Asia Pacific Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 333 Rest of Asia Pacific Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 334 Rest of Asia Pacific Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 335 Rest of Asia Pacific Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 336 Rest of Asia Pacific Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 337 LAMEA Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 338 LAMEA Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 339 LAMEA Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 340 LAMEA Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 341 LAMEA Solid-phase Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 342 LAMEA Solid-phase Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 343 LAMEA Chip-based Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 344 LAMEA Chip-based Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 345 LAMEA PCR-based Enzyme Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 346 LAMEA PCR-based Enzyme Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 347 LAMEA Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 348 LAMEA Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 349 LAMEA Antibody DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 350 LAMEA Antibody DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 351 LAMEA Viral DNA Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 352 LAMEA Viral DNA Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 353 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 354 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 355 LAMEA Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 356 LAMEA Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 357 LAMEA Gene & Cell Therapy Development Market by Country, 2017 - 2020, USD Million
TABLE 358 LAMEA Gene & Cell Therapy Development Market by Country, 2021 - 2027, USD Million
TABLE 359 LAMEA Vaccine Development Market by Country, 2017 - 2020, USD Million
TABLE 360 LAMEA Vaccine Development Market by Country, 2021 - 2027, USD Million
TABLE 361 LAMEA Disease Diagnosis Market by Country, 2017 - 2020, USD Million
TABLE 362 LAMEA Disease Diagnosis Market by Country, 2021 - 2027, USD Million
TABLE 363 LAMEA Others Market by Country, 2017 - 2020, USD Million
TABLE 364 LAMEA Others Market by Country, 2021 - 2027, USD Million
TABLE 365 LAMEA Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 366 LAMEA Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 367 LAMEA Academic & Government Research Institutes Market by Country, 2017 - 2020, USD Million
TABLE 368 LAMEA Academic & Government Research Institutes Market by Country, 2021 - 2027, USD Million
TABLE 369 LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2017 - 2020, USD Million
TABLE 370 LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2027, USD Million
TABLE 371 LAMEA Contract Research Organizations Market by Country, 2017 - 2020, USD Million
TABLE 372 LAMEA Contract Research Organizations Market by Country, 2021 - 2027, USD Million
TABLE 373 LAMEA Gene Synthesis Market by Country, 2017 - 2020, USD Million
TABLE 374 LAMEA Gene Synthesis Market by Country, 2021 - 2027, USD Million
TABLE 375 Brazil Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 376 Brazil Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 377 Brazil Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 378 Brazil Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 379 Brazil Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 380 Brazil Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 381 Brazil Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 382 Brazil Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 383 Brazil Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 384 Brazil Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 385 Argentina Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 386 Argentina Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 387 Argentina Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 388 Argentina Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 389 Argentina Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 390 Argentina Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 391 Argentina Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 392 Argentina Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 393 Argentina Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 394 Argentina Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 395 UAE Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 396 UAE Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 397 UAE Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 398 UAE Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 399 UAE Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 400 UAE Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 401 UAE Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 402 UAE Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 403 UAE Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 404 UAE Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 405 Saudi Arabia Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 406 Saudi Arabia Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 407 Saudi Arabia Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 408 Saudi Arabia Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 409 Saudi Arabia Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 410 Saudi Arabia Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 411 Saudi Arabia Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 412 Saudi Arabia Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 413 Saudi Arabia Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 414 Saudi Arabia Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 415 South Africa Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 416 South Africa Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 417 South Africa Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 418 South Africa Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 419 South Africa Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 420 South Africa Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 421 South Africa Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 422 South Africa Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 423 South Africa Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 424 South Africa Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 425 Nigeria Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 426 Nigeria Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 427 Nigeria Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 428 Nigeria Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 429 Nigeria Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 430 Nigeria Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 431 Nigeria Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 432 Nigeria Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 433 Nigeria Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 434 Nigeria Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 435 Rest of LAMEA Gene Synthesis Market, 2017 - 2020, USD Million
TABLE 436 Rest of LAMEA Gene Synthesis Market, 2021 - 2027, USD Million
TABLE 437 Rest of LAMEA Gene Synthesis Market by Method, 2017 - 2020, USD Million
TABLE 438 Rest of LAMEA Gene Synthesis Market by Method, 2021 - 2027, USD Million
TABLE 439 Rest of LAMEA Gene Synthesis Market by Service Type, 2017 - 2020, USD Million
TABLE 440 Rest of LAMEA Gene Synthesis Market by Service Type, 2021 - 2027, USD Million
TABLE 441 Rest of LAMEA Gene Synthesis Market by Application, 2017 - 2020, USD Million
TABLE 442 Rest of LAMEA Gene Synthesis Market by Application, 2021 - 2027, USD Million
TABLE 443 Rest of LAMEA Gene Synthesis Market by End User, 2017 - 2020, USD Million
TABLE 444 Rest of LAMEA Gene Synthesis Market by End User, 2021 - 2027, USD Million
TABLE 445 Key information – Genscript Biotech Corporation
TABLE 446 Key Information – Thermo Fisher Scientific, Inc.
TABLE 447 Key information – BROOKS AUTOMATION, INC
TABLE 448 Key information – Boster Biological Technology
TABLE 449 Key information – Twist Bioscience Corporation
TABLE 450 Key Information – Danaher Corporation
TABLE 451 Key information – Biomatik Corporation
TABLE 452 Key information – ProteoGenix
TABLE 453 Key information – ProMab Biotechnologies, Inc.
TABLE 454 key Information – OriGene Technologies, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2017, Dec – 2021, Nov) Leading Players
FIG 5 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2017, Jul – 2021, Aug) Leading Players
FIG 6 Recent strategies and developments: Genscript Biotech Corporation
FIG 7 Recent strategies and developments: thermo fisher scientific, inc.
FIG 8 Swot analysis: thermo fisher scientific, inc.
FIG 9 Recent strategies and developments: Twist Bioscience Corporation
FIG 10 Recent strategies and developments: Danaher Corporation